Cover image of show Science VC

Science VC

Podcast by JP Orlov

English

Technology & science

Limited Offer

2 months for 19 kr.

Then 99 kr. / monthCancel anytime.

  • 20 hours of audiobooks / month
  • Podcasts only on Podimo
  • All free podcasts
Get Started

About Science VC

Science VC explores the intersection of deeptech startups and venture capital. Each episode features conversations with startup founders, venture capitalists, and industry experts. Discover their stories, lessons learned, and predictions for the future.  Learn more about the challenges and opportunities of fundraising for venture-backed startups innovating in agtech, biotech, energy, foodtech, healthtech, and sustainability.

All episodes

8 episodes

episode Why Not All Traction Is Equal | Aligning Latam’s Agtech Innovation with Industry Needs | The Role of LPs in Early VC Investing | Long-Term Thinking in Fundraising, with Galit Flasterstein, Managing Partner @ Danta Fund | Ep 8 artwork

Why Not All Traction Is Equal | Aligning Latam’s Agtech Innovation with Industry Needs | The Role of LPs in Early VC Investing | Long-Term Thinking in Fundraising, with Galit Flasterstein, Managing Partner @ Danta Fund | Ep 8

Biodiversity as an Advantage Galit is a Managing Partner at Danta Fund, a VC firm that backs early-stage agritech startups in Latin America. Danta Fund has the mission of filling three main voids in Latin America: funding in early-stage agri-tech startups, mentorship to guide their founders, and connection with larger markets to help them grow. Topics in this episode 0:00 Intro 0:57 Galit’s Path From Founder to VC   5:12 How Danta’s Mentors Help Startups   7:08 Danta’s North Star for Startup Selection   9:24 What Makes an LOI Count   10:37 Helping Startups Enter Global Markets   14:28 How Corporates Can Engage Startups   21:57 Why Danta Passes on Startups   25:08 Common Founder Aha Moments   26:49 Why LPs Join Startup Interviews   31:50 What Founders Miss About VCs   33:35 How LATAM Agtech Differs Globally   38:04 Finding & Validating Customers   41:21 What Drives Demand for Sustainability   44:50 Saying No to High-Risk Startups   47:17 Why Danta Focuses on the U.S.   52:27 Who Should Apply to Danta Fund   53:32 Connect With Galit  Connect with Galit on LinkedIn https://www.linkedin.com/in/galitflasterstein/ Follow Danta Fund on LinkedIn https://www.linkedin.com/company/danta-fund/ Visit Danta Fund's Website and Subscribe to their Newsletter https://dantafund.com/ Email Galit galit@dantafund.com Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/ Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc Follow Science VC on Instagram https://www.instagram.com/science.vc Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC Subscribe to our Newsletter https://substack.com/@jporlov Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

17 Apr 2025 - 54 min
episode Unlocking Unsung Potential | LATAM Biotech’s Global Path | What Investors Really Look For | Avoiding Unforced Errors | Why Tulsa? | Building Cross-Border Deeptech Startups, with Michael Basch, GP and CEO @ Atento Capital | Ep 7 artwork

Unlocking Unsung Potential | LATAM Biotech’s Global Path | What Investors Really Look For | Avoiding Unforced Errors | Why Tulsa? | Building Cross-Border Deeptech Startups, with Michael Basch, GP and CEO @ Atento Capital | Ep 7

Why not Tulsa? Michael is the Founder, CEO, and General Partner of Atento Capital, a pre-seed and seed-stage VC firm focused on partnering with founders to build technology around healthcare, climate-tech, and business services. Topics in this episode 0:00 Intro 1:13 Michael’s Career Journey: From Founder to VC 4:07 The Origin Story of Atento Capital 5:04 Backing from the George Kaiser Family Foundation 10:13 Why Atento Capital Partnered with GRIDX 12:50 Tulsa’s Startup Ecosystem 20:43 How Being a Founder Shapes Michael’s Investment Approach 25:40 Explaining Science Simply to Investors 30:42 The Convergence of Exponential Technologies 34:19 Capital Concentration in Mega Funds 46:01 What to Include in Effective Investor Updates 48:18 Inside the Atento Capital x GRIDX Demo Day 50:35 What’s Next for Atento Capital 52:02 Connect With Michael Connect with Michael on LinkedIn   https://www.linkedin.com/in/mikebasch/ Follow Atento Capital on LinkedIn  https://www.linkedin.com/company/atento-capital/posts/?feedView=all  Visit Atento Capital’s Website https://www.atentocapital.com/  Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/ Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc Follow Science VC on Instagram https://www.instagram.com/science.vc Subscribe to Science VC on Spotify https://open.spotify.com/show/4XcR1Efx8SUqZqMZROQfQl Subscribe to our Newsletter https://substack.com/@jporlov Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

10 Apr 2025 - 52 min
episode Why No Idea Is Truly Unique | Leveraging Warm Intros and Mentorships | Communicating Urgency and Opportunities to VCs | Success Beyond Funding | Inside NYU’s Acceleration Program with Khoa Ma, Associate Director @ Endless Frontier Labs | Ep 6 artwork

Why No Idea Is Truly Unique | Leveraging Warm Intros and Mentorships | Communicating Urgency and Opportunities to VCs | Success Beyond Funding | Inside NYU’s Acceleration Program with Khoa Ma, Associate Director @ Endless Frontier Labs | Ep 6

Are there unique ideas anymore? Khoa Ma is an Associate Director at Endless Frontier Labs, a program at NYU Stern School of Business for early-stage science and technology startups.  Topics in this episode 0:00 Intro 1:07 Khoa’s Career Path 3:22 How Endless Frontier Labs Evaluates Startups 8:45 What Gets Startups Into Endless Frontier Labs 11:22 Most Impressive Startup Pitch 14:49 Maximizing Mentor Relationships 18:38 Building Investor Connections 26:20 Measuring Success Beyond Funding 29:33 Showing Traction Pre-Revenue 33:16 VC Blind Spots in Deeptech 36:32 Separating Sci-Fi From Reality 39:13 Underrated Deeptech Opportunities 42:31 Communicating Urgency to Investors 45:14 Founders’ Aha Moments 48:50 Best Cold Outreach Examples 51:55 No Unique Ideas Anymore 57:28 Reading Books vs. Doing 1:00:22 Who Should Apply to Endless Frontier Labs 1:01:46 Connect With Khoa Connect with Khoa on LinkedIn https://www.linkedin.com/in/khoahma/ Follow Endless Frontier Labs on LinkedIn https://www.linkedin.com/company/endlessfrontierlabs/posts/?feedView=all Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/ Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc Follow Science VC on Instagram https://www.instagram.com/science.vc Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC Subscribe to our Newsletter https://substack.com/@jporlov Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

3 Apr 2025 - 1 h 3 min
episode Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana, CEO @ APEXzymes | Ep 5 artwork

Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana, CEO @ APEXzymes | Ep 5

Can a single innovation unlock multiple billion-dollar markets? Larissa is the CEO of APEXzymes, a Brazilian biotech startup that produces cost-effective enzymes for sustainable industrial applications. During our conversation, Larissa shares her journey from chemical engineering to venture capital and entrepreneurship. Topics in this episode 0:00 Intro 1:06 From Chemical Engineer to VC to Founder 4:56 Why Leave Venture Capital to Build a Startup? 6:38 How Self-Doubt Can Drive Innovation 8:25 Advice Before Starting APEXzymes 9:34 What Are Enzymes and Why Do They Matter? 12:19 APEXzymes’ Value Proposition 13:40 What Investors Miss About APEXzymes 17:13 Key Markets: Biofuels, Cattle Feed & More 19:48 How Enzymes Boost Productivity and Cut Methane 22:11 Early Commercial Traction 23:58 Communicating Traction to Investors 27:50 Turning Enzyme Strains Into Patentable Assets 32:43 Balancing Focus vs. Market Size 38:12 Lessons from Fundraising and Non-Dilutive Grants 43:33 What GRIDX Saw in APEXzymes 46:05 Building Trust With Co-Founders 49:00 Aligning Weekly Tasks With Long-Term Vision 55:22 What’s Next for APEXzymes? Follow APEXzymes on LinkedIn https://www.linkedin.com/company/apexzymes/posts/?feedView=all Connect with Larissa on LinkedIn https://www.linkedin.com/in/larissadefv/ Email Larissa larissa.viana@apexzymes.com Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/ Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc Follow Science VC on Instagram https://www.instagram.com/science.vc Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC Subscribe to our Newsletter https://substack.com/@jporlov Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

27 Mar 2025 - 57 min
episode The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4 artwork

The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

Is it possible to transform carbon emissions into everyday products? Alex is the CEO of CERT Systems, a Canadian climatetech startup that converts CO2 emissions into high-value chemicals. In this episode, Alex shares his journey from the lab bench to raising non-dilutive capital. Topics in this episode 0:00 Intro  1:16 Founding CERT Systems  3:14 Why Now for CO2 Conversion?  5:33 Unlocking Commercial Potential  8:52 Communicating Sustainability  10:45 Why Petrochemical Companies Care  13:59 Integrating CERT’s Tech  16:33 Why Investors Should Pay Attention  21:29 Biggest Bottleneck for CO2 Chemicals  24:36 Best Markets for CERT’s Tech  29:14 Scaling from Lab to Market  33:08 First Adopters of CO2 Ethylene  37:07 Ethylene’s Role in Aviation Fuel  41:43 Raising Non-Dilutive Funding  44:28 De-Risking Climate Tech Startups  47:52 Protecting IP in Deeptech  54:15 CERT’s Role in Sustainability’s Future  56:18 What’s Next for CERT?  Connect with Alex on LinkedIn https://www.linkedin.com/in/ipalex/?originalSubdomain=ca Follow CERT on LinkedIn https://www.linkedin.com/company/co2cert/posts/?feedView=all Email Alex alex@co2cert.com Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/ Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc Follow Science VC on Instagram https://www.instagram.com/science.vc Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC [https://www.youtube.com/@ScienceVC] Subscribe to our Newsletter https://substack.com/@jporlov Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

19 Mar 2025 - 58 min
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
Rigtig god tjeneste med gode eksklusive podcasts og derudover et kæmpe udvalg af podcasts og lydbøger. Kan varmt anbefales, om ikke andet så udelukkende pga Dårligdommerne, Klovn podcast, Hakkedrengene og Han duo 😁 👍
Podimo er blevet uundværlig! Til lange bilture, hverdagen, rengøringen og i det hele taget, når man trænger til lidt adspredelse.

Choose your subscription

Most popular

Limited Offer

Premium

20 hours of audiobooks

  • Podcasts only on Podimo

  • No ads in Podimo shows

  • Cancel anytime

2 months for 19 kr.
Then 99 kr. / month

Get Started

Premium Plus

Unlimited audiobooks

  • Podcasts only on Podimo

  • No ads in Podimo shows

  • Cancel anytime

Start 7 days free trial
Then 129 kr. / month

Start for free

Only on Podimo

Popular audiobooks

Get Started

2 months for 19 kr. Then 99 kr. / month. Cancel anytime.